249 related articles for article (PubMed ID: 3013156)
1. Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.
Pyne NJ; Cooper ME; Houslay MD
Biochem J; 1986 Mar; 234(2):325-34. PubMed ID: 3013156
[TBL] [Abstract][Full Text] [Related]
2. The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity.
Pyne NJ; Cooper ME; Houslay MD
Biochem J; 1987 Feb; 242(1):33-42. PubMed ID: 3036087
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
Azhar S; Menon KM
Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
[TBL] [Abstract][Full Text] [Related]
4. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
Yamamoto T; Yamamoto S; Manganiello VC; Vaughan M
Arch Biochem Biophys; 1984 Feb; 229(1):81-9. PubMed ID: 6322693
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
Minneman KP
J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
[TBL] [Abstract][Full Text] [Related]
6. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
7. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
8. Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activity in rabbit ventricular myocardium: relations to the effects of cardiotonic drugs.
Kithas PA; Artman M; Thompson WJ; Strada SJ
Circ Res; 1988 Apr; 62(4):782-9. PubMed ID: 2832097
[TBL] [Abstract][Full Text] [Related]
9. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
Nagasaka A; Hidaka H
Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
11. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
Grant PG; Mannarino AF; Colman RW
Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
[TBL] [Abstract][Full Text] [Related]
14. Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.
Hidaka H; Yamaki T; Ochiai Y; Asano T; Yamabe H
Biochim Biophys Acta; 1977 Oct; 484(2):398-407. PubMed ID: 199262
[TBL] [Abstract][Full Text] [Related]
15. Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.
Marchmont RJ; Ayad SR; Houslay MD
Biochem J; 1981 Jun; 195(3):645-52. PubMed ID: 6274308
[TBL] [Abstract][Full Text] [Related]
16. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
17. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
Ho C; Teo TS; Desai R; Wang JH
Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
Mullaney I; Clegg RA
Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
[TBL] [Abstract][Full Text] [Related]
19. An insulin mediator preparation serves to stimulate the cyclic GMP activated cyclic AMP phosphodiesterase rather than other purified insulin-activated cyclic AMP phosphodiesterases.
Pyne NJ; Houslay MD
Biochem Biophys Res Commun; 1988 Oct; 156(1):290-6. PubMed ID: 2845976
[TBL] [Abstract][Full Text] [Related]
20. Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver.
Boyes S; Loten EG
Eur J Biochem; 1988 Jun; 174(2):303-9. PubMed ID: 2838272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
